These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 25503143

  • 21. Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.
    Gieseler F, Nüssler V, Brieden T, Kunze J, Valsamas S.
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):25-8. PubMed ID: 9476145
    [Abstract] [Full Text] [Related]

  • 22. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
    Stiewe T, Parssanedjad K, Esche H, Opalka B, Pützer BM.
    Cancer Res; 2000 Jul 15; 60(14):3957-64. PubMed ID: 10919674
    [Abstract] [Full Text] [Related]

  • 23. Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines.
    Quillet-Mary A, Mansat V, Duchayne E, Come MG, Allouche M, Bailly JD, Bordier C, Laurent G.
    Leukemia; 1996 Mar 15; 10(3):417-25. PubMed ID: 8642856
    [Abstract] [Full Text] [Related]

  • 24. Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
    Gao C, Liu SG, Lu WT, Yue ZX, Zhao XX, Xing TY, Chen ZP, Zheng HY, Li ZG.
    Mol Med Rep; 2020 Oct 15; 22(4):2905-2915. PubMed ID: 32945392
    [Abstract] [Full Text] [Related]

  • 25. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
    Rogalska A, Gajek A, Szwed M, Jóźwiak Z, Marczak A.
    Toxicol In Vitro; 2011 Dec 15; 25(8):1712-20. PubMed ID: 21896327
    [Abstract] [Full Text] [Related]

  • 26. [Leukemic bone marrow stromal cells in vitro protect leukemic cell line Jurkat cells from daunorubicin-induced apoptosis].
    Li ZJ, Teng BX, Chen XH, Kong PY, Wang JG, Peng XG, Yang ZZ.
    Ai Zheng; 2005 Jun 15; 24(6):672-5. PubMed ID: 15946476
    [Abstract] [Full Text] [Related]

  • 27. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.
    Côme MG, Skladanowski A, Larsen AK, Laurent G.
    Br J Cancer; 1999 Mar 15; 79(7-8):1090-7. PubMed ID: 10098741
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
    Catchpoole DR, Stewart BW.
    Cancer Res; 1993 Sep 15; 53(18):4287-96. PubMed ID: 8364925
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells.
    Ishii K, Tanaka S, Kagami K, Henmi K, Toyoda H, Kaise T, Hirano T.
    Cancer Invest; 2010 Mar 15; 28(3):220-9. PubMed ID: 19863351
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U, Danishefsky K, Traganos F, Darzynkiewicz Z.
    Clin Cancer Res; 1995 Aug 15; 1(8):873-80. PubMed ID: 9816057
    [Abstract] [Full Text] [Related]

  • 37. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM, Abnous K, Mosaffa F, Behravan J.
    J Drug Target; 2010 May 15; 18(4):277-81. PubMed ID: 19943768
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.